首頁 › 胃癌 › 德克薩斯州 › San Antonio
San Antonio, TX 的 胃癌 臨床試驗
19 項針對 胃癌 的研究正在 San Antonio（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Audie L Murphy VA Hospital, San Antonio
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
招募中2/3 期
- Texas Oncology - San Antonio, San Antonio
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
招募中1 期
- NEXT Oncology - PARENT, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
招募中1/2 期
- START South Texas Accelerated Research Therapeutics, San Antonio
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- NEXT Oncology, San Antonio
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
招募中1 期
- START - San Antonio, San Antonio
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
招募中1/2 期
- South Texas Accelerated Research Therapeutics (START), LLC, San Antonio
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
招募中1 期
- NEXT San Antonio, San Antonio
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
招募中1/2 期
- Research Site, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
招募中1/2 期
- UT Health Mays Cancer Center, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
招募中1/2 期
- Clinical Trial Site, San Antonio
IDOV-Immune for Advanced Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
招募中1 期
- NEXT Virginia, LLC, San Antonio
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
招募中1 期
- START San Antonio, LLC., San Antonio
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- NEXT Oncology /ID# 243007, San Antonio
- South Texas Accelerated Research Therapeutics (START) /ID# 276268, San Antonio
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
招募中1/2 期
- NEXT Oncology, San Antonio
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
招募中1 期
- Dren Investigational Site, San Antonio
其他城市的 胃癌 試驗
- Houston, TX42 項研究
- Boston, MA32 項研究
- New York City, NY31 項研究
- Nashville, TN28 項研究
- Baldwin Park, CA22 項研究
- Los Angeles, CA22 項研究
- Arlington, VA20 項研究
- Dallas, TX19 項研究
- St. Louis, MO18 項研究
- Grand Rapids, MI18 項研究
- Chicago, IL16 項研究
- Washington, DC16 項研究
San Antonio 的其他研究
- 非小細胞肺癌59 項研究
- 乳癌47 項研究
- 大腸直腸癌46 項研究
- 轉移性癌症44 項研究
- 癌症（所有類型）41 項研究
- 肥胖症40 項研究
- 第二型糖尿病37 項研究
- 過重34 項研究
- 卵巢癌31 項研究
- 胰臟癌31 項研究
- 前列腺癌28 項研究
- 子宮內膜癌27 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。